article · Journal of Rehabilitation Medicine
OBJECTIVE: to report on the development and global testing of the COVID-19 version of the International Classification of Functioning, Disability and Health-based Clinical Functioning Information Tool called "ClinFIT COVID-19" to collect functioning data of rehabilitation patients across the care continuum to establish an interval-scaled functioning score. DESIGN: Multicentre, cross-sectional observational study. SUBJECTS/PATIENTS: Rehabilitation patients in acute, post-acute, and long-term settings. METHODS: Three context-specific versions (13-16 ICF categories) of ClinFIT-COVID-19 were administered to collect information on patient functioning. Rasch analysis examined psychometric properties and generated conversion tables from ordinal raw scores to a 0-100 interval metric. RESULTS: Twenty-six study centres in 17 countries across the globe collected data from 1,747 patients. Problems in exercise tolerance functions were most frequently reported in the acute and post-acute settings (74.2%; 87.6%), while long-term care patients most frequently reported pain as problematic (71.1%). With a testlets approach and item splitting, all 3 ClinFIT COVID-19 versions satisfied Rasch model expectations (item-trait χ² p > 0.05; PSI 0.742-0.812), making it feasible to develop respective transformation tables. CONCLUSION: This study found the psychometric properties of ClinFIT COVID-19 acceptable. Future studies are needed to validate the use of the transformation tables to monitor functioning and evaluate intervention impact.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.2340/jrm.v57.43227
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.